Alexandra Haw, MD | |
101 Nicolls Rd, Stony Brook, NY 11794-6130 | |
(631) 689-8333 | |
Not Available |
Full Name | Alexandra Haw |
---|---|
Gender | Female |
Speciality | Pulmonary Disease |
Experience | 9 Years |
Location | 101 Nicolls Rd, Stony Brook, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538542386 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Hartford Hospital | Hartford, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hartford Hospital | 2567366016 | 827 |
Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
News Archive
A Johns Hopkins University scientist, whose team of researchers recently identified pneumonia, diarrhea, and malaria as the primary causes of death of 6 million of the world's poorest children, today called on leaders in donor and developing nations to take action to address the terrible death toll.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
With the goal of developing an accurate, powerful and fast method to automate the ana-lysis of bone strength, scientists of the ETH Zurich Departments of Mechanical and Pro-cess Engineering and Computer Science teamed up with supercomputing experts at IBM's Zurich Research Laboratory. The breakthrough method developed by the team combines density measurements with a large-scale mechanical analysis of the inner-bone microstructure.
The University of Colorado College of Nursing has been awarded a $753,817 grant from the U.S. Department of Health and Human Services, Health Resources and Services Administration, to prepare advanced practice nurses with the expertise to provide leadership for high quality healthcare in rural and medically underserved urban areas.
› Verified 3 days ago
Entity Name | Hartford Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407806391 PECOS PAC ID: 2567366016 Enrollment ID: O20031125000700 |
News Archive
A Johns Hopkins University scientist, whose team of researchers recently identified pneumonia, diarrhea, and malaria as the primary causes of death of 6 million of the world's poorest children, today called on leaders in donor and developing nations to take action to address the terrible death toll.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
With the goal of developing an accurate, powerful and fast method to automate the ana-lysis of bone strength, scientists of the ETH Zurich Departments of Mechanical and Pro-cess Engineering and Computer Science teamed up with supercomputing experts at IBM's Zurich Research Laboratory. The breakthrough method developed by the team combines density measurements with a large-scale mechanical analysis of the inner-bone microstructure.
The University of Colorado College of Nursing has been awarded a $753,817 grant from the U.S. Department of Health and Human Services, Health Resources and Services Administration, to prepare advanced practice nurses with the expertise to provide leadership for high quality healthcare in rural and medically underserved urban areas.
› Verified 3 days ago
Entity Name | Hartford Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770696643 PECOS PAC ID: 2567366016 Enrollment ID: O20031125000752 |
News Archive
A Johns Hopkins University scientist, whose team of researchers recently identified pneumonia, diarrhea, and malaria as the primary causes of death of 6 million of the world's poorest children, today called on leaders in donor and developing nations to take action to address the terrible death toll.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
With the goal of developing an accurate, powerful and fast method to automate the ana-lysis of bone strength, scientists of the ETH Zurich Departments of Mechanical and Pro-cess Engineering and Computer Science teamed up with supercomputing experts at IBM's Zurich Research Laboratory. The breakthrough method developed by the team combines density measurements with a large-scale mechanical analysis of the inner-bone microstructure.
The University of Colorado College of Nursing has been awarded a $753,817 grant from the U.S. Department of Health and Human Services, Health Resources and Services Administration, to prepare advanced practice nurses with the expertise to provide leadership for high quality healthcare in rural and medically underserved urban areas.
› Verified 3 days ago
Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
A Johns Hopkins University scientist, whose team of researchers recently identified pneumonia, diarrhea, and malaria as the primary causes of death of 6 million of the world's poorest children, today called on leaders in donor and developing nations to take action to address the terrible death toll.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
With the goal of developing an accurate, powerful and fast method to automate the ana-lysis of bone strength, scientists of the ETH Zurich Departments of Mechanical and Pro-cess Engineering and Computer Science teamed up with supercomputing experts at IBM's Zurich Research Laboratory. The breakthrough method developed by the team combines density measurements with a large-scale mechanical analysis of the inner-bone microstructure.
The University of Colorado College of Nursing has been awarded a $753,817 grant from the U.S. Department of Health and Human Services, Health Resources and Services Administration, to prepare advanced practice nurses with the expertise to provide leadership for high quality healthcare in rural and medically underserved urban areas.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Alexandra Haw, MD 85 Seymour St, Ste 923, Hartford, CT 06106-5529 Ph: () - | Alexandra Haw, MD 101 Nicolls Rd, Stony Brook, NY 11794-6130 Ph: (631) 689-8333 |
News Archive
A Johns Hopkins University scientist, whose team of researchers recently identified pneumonia, diarrhea, and malaria as the primary causes of death of 6 million of the world's poorest children, today called on leaders in donor and developing nations to take action to address the terrible death toll.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
With the goal of developing an accurate, powerful and fast method to automate the ana-lysis of bone strength, scientists of the ETH Zurich Departments of Mechanical and Pro-cess Engineering and Computer Science teamed up with supercomputing experts at IBM's Zurich Research Laboratory. The breakthrough method developed by the team combines density measurements with a large-scale mechanical analysis of the inner-bone microstructure.
The University of Colorado College of Nursing has been awarded a $753,817 grant from the U.S. Department of Health and Human Services, Health Resources and Services Administration, to prepare advanced practice nurses with the expertise to provide leadership for high quality healthcare in rural and medically underserved urban areas.
› Verified 3 days ago
Mohamed Hassan Kamel, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: Stony Brook University Hospital 101 Nicolls Road, Stony Brook, NY 11794 Phone: 631-689-8333 | |
Narinder Singh, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 101 Nicolls Rd, Stony Brook, NY 11794 Phone: 631-444-4000 | |
Dr. Andrzej Kudelka, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Pellegrino Rd, Z8151, Stony Brook, NY 11794 Phone: 631-638-0910 Fax: 631-638-0195 | |
Saverio J Barbera, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Health Science Center Nicolls Road, T-16-080, Stony Brook, NY 11794 Phone: 631-444-3575 Fax: 631-444-1054 | |
Dr. Richard Lin, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: University Hospital, L5, Stony Brook, NY 11794 Phone: 631-444-2540 | |
Dr. Ajay Malhotra, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Hsc L4 Rm 120, Stony Brook, NY 11794 Phone: 631-444-5400 Fax: 631-444-7538 | |
Dr. John Anthony Savino Iii, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1320 Stony Brook Rd Bldg D, Stony Brook, NY 11790 Phone: 212-241-1653 Fax: 212-289-6393 |